Nanologica AB (publ) (STO:NICA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3500
-0.0190 (-5.15%)
At close: Mar 27, 2026

Revenue by Segment

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Chroma
21.13M--1.56M1.91M
Chroma Growth
----18.63%-57.21%
Drug Development - DD
----10.36M
Drug Development - DD Growth
-----11.21%
Unallocated Business Support
----642.00K
Total
21.13M--1.56M12.91M
Total Growth
----87.96%-19.96%

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
China
18.28M8.43M654.00K699.00K1.31M
China Growth
116.98%1188.38%-6.44%-46.60%-60.62%
India
182.00K5.92M188.00K128.00K-
India Growth
-96.92%3046.81%46.88%--
United States of America (USA)
1.52M21.00K-276.00K103.00K
United States of America (USA) Growth
7157.14%--167.96%-74.88%
Rest of The World
1.06M175.00K601.00K452.00K1.92M
Rest of The World Growth
506.86%-70.88%32.96%-76.41%-18.99%
Sweden
----9.24M
Sweden Growth
-----7.90%
Turkey
----343.00K
Total
21.05M14.54M1.44M1.56M12.91M
Total Growth
44.80%907.48%-7.20%-87.96%-19.96%
Source: S&P Global Market Intelligence.